Critical Analysis of Stage IV Epithelial Ovarian Cancer Patients after Treatment with Neoadjuvant Chemotherapy followed by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC)

Critical Analysis of Stage IV Epithelial Ovarian Cancer Patients after Treatment with Neoadjuvant Chemotherapy followed by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC)

Background. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) after neoadjuvant chemotherapy (NACT) showed promise as initial treatment for stage IIIC (SIII) epithelial ovarian cancer (EOC); however, stage IV (SIV) outcomes are rarely reported. We assessed our experienc...

Full description

Bibliographic Details
Main Authors: Carlos A. Munoz-Zuluaga, Armando Sardi, Michelle Sittig, Vadim Gushchin, Mary C. King, Carol Nieroda, Felipe Lopez-Ramirez, Teresa P. Diaz-Montes
Format: Article
Language:English
Published: Hindawi Limited 2020-01-01
Series:International Journal of Surgical Oncology
Online Access:http://dx.doi.org/10.1155/2020/1467403

Similar Items

Similar Items